AbbVie Inc. Equity-NMS: ABBV


Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$169.91
Open :$170.63
Today's high :$171.63
Today's low :$169.9
52W low :$134.12
52W high :$182.89
1Y :27.98%
5Y :141.66%
EPS(TTM): :3.36
Shares O/S :1.77 B
Market cap :300.89 B

Compare with Other Stocks

Frequently Asked Questions

What is the share price of AbbVie Inc. today?

AbbVie Inc. (ABBV) share price as of July 13, 2024, is $170.39. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of AbbVie Inc.?

Yes, Indian Investors can invest in the AbbVie Inc. (ABBV) Share by opening an international trading account with Angel One.

How can I purchase AbbVie Inc. shares in India?

Purchasing AbbVie Inc. (ABBV) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying AbbVie Inc. (ABBV) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of AbbVie Inc.?

Yes, you can purchase fractional shares of AbbVie Inc. (ABBV) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of AbbVie Inc.?

The market capitalization of AbbVie Inc. on July 13, 2024, is $300.89 B.

In which sector AbbVie Inc. belongs?

AbbVie Inc. operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

What documents are required to invest in AbbVie Inc. stocks?

In order to invest in AbbVie Inc. (ABBV) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About AbbVie Inc.

AbbVie Inc. is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in therapeutic categories, including immunology, which include Humira, Skyrizi and Rinvoq; oncology, which include Imbruvica, Venclexta/Venclyxto, Epkinly and Elahere; aesthetics products, which include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience, which include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy and Qulipta; eye care, which consists of Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella and Synthroid. It offers NX-13, a first-in-class, oral NLRX1 agonist, for the treatment of ulcerative colitis (UC) and Crohn's disease (CD). It also offers CEL383, a first-in-class anti-TREM1 antibody, for the treatment of inflammatory bowel disease.